Meet the advocates who are making a difference!
Low Dose Naltrexone faces an uphill battle when it comes to research, because it is an inexpensive generic drug. That's why patients have taken it upon themselves to raise awareness and funds. And it is working!
LDN AWARENESS DAY - Wednesday 21 October 2009
Meet Vicki Finlayson on the Capitol steps May 19th 2pm
Send Governor Schwarzenegger an email and tell him to meet with Vicki!
Vicki Finlayson, a patient with multiple sclerosis (MS), used to have trouble walking from her living room to her kitchen. Now, with the help of one generic medication prescribed off-label, she is walking 53 miles from her home in Auburn California to Sacramento. Vicki is raising funds for research into the drug protocol that brought her MS into remission, low dose naltrexone (LDN). Besides its benefits in MS, LDN has been shown to improve many different autoimmune, oncological, and neurodegenerative conditions.
Vicki's conviction is as a strong as her stride. "I've been calling and writing Governor Schwarzenegger office. To make sure he hears me, I'm marching up the Capital steps! This medication deserves immediate research funding, it can help more than MS, it stabilizes the immune system, so it helps all manner of diseases, like cancer, Parkinson's, Lupus - many autoimmune disorders." Join Vicki in her fight. For more information, see www.LDNers.org
Vicki's fundraiser in 2006 was responsible for raising
the majority of the funds for the first human trial of LDN
for MS at UCSF. Her current efforts are directed towards the
LDN research at Penn State, where
Dr. Ian Zagon has made key discoveries about LDN's
effects on the immune system.
Focus on Low Dose Naltrexone: Vicki Finlayson's March to the
California State Capitol
A promising MS drug has her walkin' - Vicki Finlayson says LDN
has her walking strongly again
Vicki Finalyson has raised over $17,000 in funds for LDN research
Vicki's LDN story in her own
For Vicki's contact info, please send an email.
2008 LDNers.org. All rights reserved